- Prescribing Advice for GPs - https://www.prescriber.org.uk -

SMC May Update

The Scottish Medicines Consortium has issued its monthly advice on new medicines.

Aliskiren (Rasilez®) has been rejected for the treatment of essential hypertension. Escitalopram (Cipralex®) has been rejected for the treatment of social anxiety disorder. Both rejections we made because the manufacturers failed to make a submission.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected medicines should be avoided.